A carregar...
Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes
It is important for patients that treatments for diabetes not increase cardiovascular (CV) risk. The objective of this analysis was to examine retrospectively the CV safety of exenatide BID, a GLP-1 receptor agonist approved for treating hyperglycemia in patients with type 2 diabetes not adequately...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3070629/ https://ncbi.nlm.nih.gov/pubmed/21410975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-10-22 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|